Importantly, RORα was low expression in liver of patients with NASH (Ou et al., 2013), and treatment with RORα activator could alleviate NASH (Han et al., 2014, 2017). The gene discussed is RORA; the disease is metabolic dysfunction-associated steatohepatitis.